Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
U.S. stocks traded mostly lower, with the Nasdaq Composite dropping over 60 points on Wednesday. Here are some big stocks recording losses in today’s session.
Home furnishing brand Lovesac Co (NASDAQ:LOVE) reported third-quarter FY22 sales growth of 15.5% year-on-year to $134.80 million, beating the consensus of $134.46…
Mr. Nelson continued, "We believe we are well positioned for the all-important fourth quarter holiday-season where early signs point to strong cash flow generation for the quarter. At the same time, we are
Companies Reporting Before The Bell
• Academy Sports (NASDAQ:ASO) is estimated to report quarterly earnings at $1.59 per share on revenue of $1.55 billion.